As of April 1, 2026, Tonix Pharmaceuticals Holding Corp. (TNXP) trades at $13.68, marking a 0.51% decline in the latest trading session. This analysis explores key technical levels, recent market context for the biopharmaceutical stock, and potential near-term price scenarios based on current trading patterns. No recent earnings data is available for TNXP as of this writing, so price action is currently driven primarily by sector sentiment and technical flows rather than quarterly fundamental pe
TNXP Stock Analysis: Tonix Pharmaceuticals Holding Corp dips 0.51 pct to 13.68
TNXP - Stock Analysis
4063 Comments
1844 Likes
1
Sharil
Elite Member
2 hours ago
Are you secretly a superhero? 🦸♂️
👍 140
Reply
2
Thonda
Trusted Reader
5 hours ago
This feels like I should run but I won’t.
👍 11
Reply
3
Maryagnes
Community Member
1 day ago
Short-term corrections may offer better risk-reward opportunities.
👍 213
Reply
4
Delfa
New Visitor
1 day ago
Expert US stock margin analysis and operational efficiency metrics to identify companies with improving profitability. We track key performance indicators that often signal fundamental improvement before it shows up in earnings.
👍 83
Reply
5
Rinka
Active Contributor
2 days ago
This made me smile from ear to ear. 😄
👍 273
Reply
Disclaimer: Not investment advice. For informational purposes only. Past performance does not guarantee future results. Trading involves substantial risk of loss.